ZimVie Inc. (NASDAQ:ZIMV – Get Free Report) major shareholder Camber Capital Management Lp sold 525,000 shares of the firm’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $17.71, for a total value of $9,297,750.00. Following the sale, the insider now directly owns 2,725,000 shares in the company, valued at approximately $48,259,750. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
ZimVie Stock Up 3.9 %
Shares of ZimVie stock traded up $0.65 on Tuesday, hitting $17.15. The company had a trading volume of 747,501 shares, compared to its average volume of 368,975. ZimVie Inc. has a twelve month low of $6.52 and a twelve month high of $22.40. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.68 and a quick ratio of 2.23. The stock has a 50-day moving average of $18.05 and a 200-day moving average of $17.54. The firm has a market capitalization of $468.01 million, a P/E ratio of -1.23 and a beta of 2.18.
ZimVie (NASDAQ:ZIMV – Get Free Report) last announced its earnings results on Thursday, August 1st. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.04). ZimVie had a positive return on equity of 2.09% and a negative net margin of 63.84%. The company had revenue of $116.81 million during the quarter. During the same period in the previous year, the firm posted $0.17 earnings per share. Research analysts predict that ZimVie Inc. will post 0.63 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Separately, Needham & Company LLC increased their price target on ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Friday.
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Read More
- Five stocks we like better than ZimVie
- Why Are These Companies Considered Blue Chips?
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- How to Calculate Inflation Rate
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- Investing in the High PE Growth Stocks
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.